The 20 Best Obesity Doctors Near Me in Ann Arbor, MI

Amy E. Rothberg, MD, DABOM is Clinical Professor of Internal Medicine in the Division of Metabolism, Endocrinology and Diabetes (MEND) and Director of the MEND Weight Management Clinic, Research Professor of Nutritional Sciences and Director of Rewind, a virtual weight management and diabetes treatment program. She is an adjunct Professor in the School of Public Health at the University of Michigan.Dr. Rothberg served both her internship and residency in the Department of Internal Medicine at the University of Michigan Medical Center in Ann Arbor. She then completed the fellowship program in the Metabolism, Endocrinology & Diabetes at the University of Michigan Health System in Ann Arbor and then joined the faculty.Dr. Rothberg holds, or is a Co-Investigator, on research grants from the Michigan Nutrition Obesity Research Center, the Michigan Diabetes Research Center, and the National Institutes of Health. Dr. Rothberg is rated as an Elite provider by MediFind in the treatment of Obesity. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Obesity in Children, Familial Partial Lipodystrophy, and Gastric Bypass. Dr. Rothberg is board certified in Endocrinology, Diabetes & Metabolism.

Dana A. Telem, MD, MPH, is the Section Head of General Surgery, the Associate Chair for Quality and Patient Safety, and the Lazar J. Greenfield Professor of Surgery. Dr. Telem completed her surgical training at The Mount Sinai Medical Center in New York and her fellowship in Minimally Invasive and Bariatric Surgery at the Massachusetts General Hospital. Dr. Telem also completed a Master’s in Public Health in the Executive Master’s of Healthcare Management program at the Columbia University Mailman School of Public Health.She serves on the editorial boards of Annals of Surgery and Surgery for Obesity and Related Diseases, is a Subject Editor for Surgical Endoscopy and a Section Editor for Hernia. Her research and commentaries have been published in several prominent journals such as the Journal of the American Medical Association (JAMA) and Annals of Surgery. She serves on the SAGES and Foundation for Surgical Fellowships Board of Governors, and holds key leadership positions across several organizations and societies focused on quality and patient safety, as well as diversity and inclusion.Clinical Specialization:Her clinical practice is devoted to minimally invasive therapies focused on hernia, benign diseases of the esophagus and morbid obesity. Dr. Telem is rated as an Elite provider by MediFind in the treatment of Obesity. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Hernia, Obesity, Umbilical Hernia, Sleeve Gastrectomy, and Gallbladder Removal. Dr. Telem is board certified in Surgery.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as a Distinguished provider by MediFind in the treatment of Obesity. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as a Distinguished provider by MediFind in the treatment of Obesity. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Brigid Gregg is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Gregg is rated as an Advanced provider by MediFind in the treatment of Obesity. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Obesity, Diabetes Insipidus (DI), and Neurohypophyseal Diabetes Insipidus.

Jonathan F. Finks, M.D, is a Assistant Professor in the Division of Minimally Invasive Surgery, Section of General Surgery. Dr. Finks graduated from Harvard College in Cambridge, Massachusetts with a degree in English Literature in 1991. Dr. Finks received his medical degree from the University of California, Irvine College of Medicine, Irvine, California, in 1998. He completed his General Surgery residency in June of 2003, at the University of Cincinnati College of Medicine in Ohio. Dr. Finks went on to complete a two year fellowship in Minimally Invasive Surgery at Oregon Health and Science University in Portland, Oregon. He joined the faculty at the University of Michigan Health System in August of 2005.Dr. Finks clinical interests are Minimally Invasive Surgery, Bariatric Surgery, Gastroesophageal Reflux Disease, and Achalasia.His research focus is Clinical Outcomes of Bariatric Surgery. Dr. Finks is rated as a Distinguished provider by MediFind in the treatment of Obesity. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Obesity, Hernia, Hiatal Hernia, Sleeve Gastrectomy, and Gastrectomy. Dr. Finks is board certified in Surgery.

Justin B. Dimick, M.D., M.P.H. is the Frederick A. Coller Distinguished Professor of Surgery and Chair of the Department of Surgery at the University of Michigan. Dr. Dimick is a graduate of Cornell University and Johns Hopkins Medical School. He completed his surgical training at the University of Michigan and a health services research fellowship at the Dartmouth Institute for Health Policy & Clinical Practice. Dr. Dimick has served in several national leadership positions, including President of the Association for Academic Surgery (AAS), Chair of the Health Services Organization and Delivery (HSOD) Study Section at the NIH, Associate Editor at Annals of Surgery, and the Surgical Innovation Editor at JAMA Surgery. He has served as an advisor on quality and health policy for several organizations, including the BlueCross BlueShield Association (BCBSA), the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP), US News and World Reports Best Hospital Rankings, and the Medicare Payment Advisory Commission (MedPAC).Clinical Specialization:Dr. Dimick's clinical practice is primarily devoted to advanced laparoscopy, including treatment of morbid obesity, gastroesophageal reflux (GERD), paraesophageal hernias, abdominal wall hernias, and other benign and neoplastic diseases of the stomach, spleen, and foregut. He is the editor of the widely read surgical textbook, Clinical Scenarios in Surgery: Decision Making and Operative Technique, published by Lippincott (2018). Dr. Dimick is rated as a Distinguished provider by MediFind in the treatment of Obesity. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hernia, Obesity, Umbilical Hernia, Sleeve Gastrectomy, and Gastrectomy. Dr. Dimick is board certified in Surgery.

PHD, Massachusetts Institute of Technology, Cambridge, Massachusetts, 2001 MPH, Harvard School of Public Health, Boston, Massachusetts, 2008. Dr. Speliotes is rated as a Distinguished provider by MediFind in the treatment of Obesity. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Obesity, Cirrhosis, and Neuroma Biliary Tract. Dr. Speliotes is board certified in Internal Medicine and Gastroenterology.

As director of the Michigan Metabolomics and Obesity Center, Dr. Charles F. Burant facilitates the network of obesity related researchers on the U-M campus which results in enhancing collaborative studies and speeding the translation of basic science findings into clinically useful therapies for metabolic diseases including obesity, Type 2 diabetes and related metabolic disorders.Dr. Burant earned both his medical degree and doctorate of philosophy in molecular and cellular biology from the Medical University of South Carolina in Charleston. His internship and residency were served at the University of California, San Francisco, and he completed his fellowship in the Department of Medicine, Endocrinology Section at the University of Chicago. He joined the University of Michigan faculty in 1999. Dr. Burant is rated as an Advanced provider by MediFind in the treatment of Obesity. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D). Dr. Burant is board certified in Endocrinology, Diabetes & Metabolism.

William H. Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes and Professor of Epidemiology in the School of Public Health. He completed his undergraduate degree at Yale University and received his medical degree from Boston University. He gained a Masters of Public Health (Epidemiology) from the University of Michigan. Professor Herman's interests include clinical diabetes and diabetes epidemiology, especially in the areas of surveillance, screening, treatment, cost-effective analysis, and health policy. He has authored more than 400 original research papers, reviews and textbook chapters and is U-M Principal Investigator for the Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC), Diabetes Prevention Program (DPP), Diabetes Prevention Program Outcomes Study (DPPOS), and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Professor Herman received the American Diabetes Association's Kelly West Award for outstanding achievement in diabetes epidemiology in 2006 and the U-M Dean's Award for Clinical and Health Services Research in 2007. From 2018 to 2021, he chaired the National Clinical Care Commission, a federal advisory committee charged with advising the Congress how to leverage federal policies and programs to better prevent and control diabetes in the United States. He has been recognized by Best Doctors as a Best Doctor in America for more than 10 years. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Obesity. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Diabetic Neuropathy, and Gastric Bypass. Dr. Herman is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Advanced provider by MediFind in the treatment of Obesity. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Allison Schulman, MD, MPH, FASGE, FACG is an Associate Professor and dually appointed in the Division of Gastroenterology and Hepatology and the Department of Surgery. She received her bachelor's degree from Cornell University in Ithaca, New York, and her medical degree from Weill Cornell Medical College in New York City, where she was inducted into the Alpha Omega Alpha (AOA) Medical Honor Society. She received a Master’s in Public Health (MPH) at Harvard University. She completed her residency in Internal Medicine at the Brigham and Women's Hospital in Boston, MA. Following residency training, Dr. Schulman completed fellowship in Gastroenterology, and went on to complete two additional fellowships in Bariatric Endoscopy followed by Advanced/Therapeutic Endoscopy. All of her training was at Harvard/Brigham and Women's Hospital. She joined faculty at Michigan in 2017 and was appointed Director of Bariatric Endoscopy and more recently selected as Chief of Endoscopy in 2023.Dr. Schulman's research has focused on endoscopic management of obesity and device development/innovation in therapeutic endoscopy. She is specifically interested in the management of complications following bariatric surgery, primary endoscopic therapy for obesity, and therapeutic endoscopic ultrasound (EUS). She also has interests in interventional hepatology and ERCP.She is a member of the Clinical Excellence Society and participates in committees through many gastroenterology and surgical societies, and is the current Chair of the Association of Bariatric Endoscopy (ABE/ASGE). Dr. Schulman is rated as a Distinguished provider by MediFind in the treatment of Obesity. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Gastrointestinal Fistula, Choledocholithiasis, Hereditary Pancreatitis, Gastric Bypass, and Endoscopy. Dr. Schulman is board certified in Gastroenterology.

David Olson earned his M.D. and Ph.D. at the University of Michigan (the latter in Cellular and Molecular Biology). He served his internship and residency at Children’s Hospital Boston, followed by a fellowship in pediatric endocrinology and metabolism at Children’s Hospital Boston/Joslin Diabetes Center. Prior to returning to the University of Michigan, Dr. Olson was on staff at Children's Hospital Boston and affiliated with the Department of Newborn Medicine at Brigham and Women’s Hospital. His postdoctoral research was performed at Beth Israel Deaconess Medical Center, Division of Endocrinology. Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. Additional studies using neuron-specific genetic changes are underway to clarify the molecular basis of daily biologic rhythms and explore how disruption of these rhythms predisposes organisms (rodents and humans) to pathologic changes in metabolism. Dr. Olson is rated as an Experienced provider by MediFind in the treatment of Obesity. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), and Familial Short Stature (FSS). Dr. Olson is board certified in Pediatric Endocrinology.

Ram Menon is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Menon is rated as an Experienced provider by MediFind in the treatment of Obesity. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Congenital Hypothyroidism, Short Stature (Growth Disorders), Pediatric Growth Hormone Deficiency, and Thyroidectomy. Dr. Menon is board certified in Pediatric Endocrinology.

Scott Regenbogen, MD, MPH is a Professor of Surgery and Division Chief of Colorectal Surgery. He graduated from Princeton University with an A.B. in psychology, and received his M.D. degree from the University of California, San Francisco. He completed General Surgery residency at the Massachusetts General Hospital, including three years as a Postdoctoral Fellow in Health Services Research, and was awarded a Master’s in Public Health from the Harvard School of Public Health. He then completed fellowship training in Colon and Rectal Surgery at the Lahey Clinic, and joined the faculty of the University of Michigan in 2011.Clinical SpecializationDr. Regenbogen's clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. He has a particular interest in the use of laparoscopic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Regenbogen is rated as an Experienced provider by MediFind in the treatment of Obesity. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Hernia Surgery. Dr. Regenbogen is board certified in Surgery and Colon & Rectal Surgery.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Obesity. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy. Dr. Ajluni is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Experienced provider by MediFind in the treatment of Obesity. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Eric Buras is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Buras is rated as an Experienced provider by MediFind in the treatment of Obesity. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Neurohypophyseal Diabetes Insipidus, Panhypopituitarism, and Diabetes Insipidus (DI).

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Obesity. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism. Dr. Kutahyalioglu is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Obesity. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.